KI
AMPH icon

Kalmar Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Kalmar Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.66M Sell
114,470
-126,178
-52% -$1.98M 0.37% 78
2016
Q4 		$4.43M Sell
240,648
-13,770
-5% -$268K 0.23% 109
2016
Q3 		$4.83M Buy
254,418
+43,703
+21% +$793K 0.22% 112
2016
Q2 		$3.4M Buy
+210,715
New +$2.97M 0.15% 115

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Kalmar Investments's AMPH Position: Q1 2017 in Review

Kalmar Investments reduced its Amphastar Pharmaceuticals (AMPH) stake by 52% in Q1 2017, selling an estimated $1.98M and leaving 114,470 shares worth $1.66M. The position accounts for 0.37% of the portfolio, ranked #78.

Kalmar Investments first reported a position in AMPH in Q2 2016 and has held it in 4 quarters since. The position peaked at $4.83M in Q3 2016. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2017.

  • Kalmar Investments held 114,470 shares of Amphastar Pharmaceuticals worth $1.66M as of Q1 2017.
  • Kalmar Investments sold 126,178 Amphastar Pharmaceuticals shares in Q1 2017, an estimated $1.98M.
  • Amphastar Pharmaceuticals made up 0.37% of Kalmar Investments's portfolio in Q1 2017, its #78 holding.
  • Kalmar Investments first reported a position in Amphastar Pharmaceuticals in Q2 2016 and has held it in 4 quarters since.
  • Kalmar Investments's Amphastar Pharmaceuticals position peaked at $4.83M in Q3 2016.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.